In an ambitious initiative to tackle the growing concern of hypertension in India, Glenmark Pharmaceuticals Limited (Glenmark) concluded its ‘Hypertension Awareness Month’ this May. Partnering with over 1,000 healthcare professionals (HCPs) from 250+ cities and towns, the campaign organized more than 400 public awareness rallies and screening camps nationwide.
These rallies featured informative sessions led by HCPs, who provided comprehensive insights into the signs, symptoms, and preventive measures of hypertension. The subsequent blood pressure screening camps allowed the public to assess their blood pressure levels, reaching out to 6 million adults across the country.”We at Glenmark are firmly committed to creating awareness and making a meaningful impact in the fight against hypertension in India,” said Mr. Alok Malik, President & Head of India Formulations at Glenmark Pharmaceuticals Ltd. “Through our initiatives, we aim to empower individuals to take charge of their health by detecting hypertension early, as elevated blood pressure poses future cardiovascular risks.”
Glenmark’s efforts have been bolstered by its #TakeChargeAt18 campaign, aiming to screen and educate Indian adults over 18 years old. In 2020, Glenmark launched the world’s first-ever hypertension awareness symbol, “The BP logo,” in collaboration with the Hypertension Society of India (HSI) and the Association of Physicians of India (API).With approximately 35.5% of Indian adults affected by hypertension, this campaign is crucial. Cardiovascular disease, driven largely by hypertension, is the leading cause of death in India, accounting for nearly a quarter of all mortality cases. The nation’s goal of reducing hypertension prevalence by 25% by 2025 highlights the importance of such awareness campaigns.
